(Q41789989)

English

Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue

scientific article published on March 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue (English)

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

Ferrier CM

1

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

de Witte HH

2

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

Straatman H

3

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

van Tienoven DH

4

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

van Geloof WL

5

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

Rietveld FJ

6

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

Sweep CG

7

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

Ruiter DJ

8

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

van Muijen GN

9

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

language of work or name

0 references

publication date

1 March 1999

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

79

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

9-10

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

1534-1541

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690245

0 references

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362713

6 June 2018

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362713

6 June 2018

Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362713

6 June 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362713

6 June 2018

The plasminogen activation system in tumour invasion and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362713

6 June 2018

Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362713

6 June 2018

Prognostic role of urokinase-type plasminogen activator in human gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362713

6 June 2018

The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362713

6 June 2018

Immunolocalization of urokinase-type plasminogen activator in adenomas and carcinomas of the colorectum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362713

6 June 2018

Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362713

6 June 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362713

6 June 2018

Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steroid receptors in breast cancer: sources of inter-laboratory variation in dextran-charcoal assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiation in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of the plasminogen activation system in patients with gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and Metastasis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10188903

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6690245

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

Dimensions Publication ID

0 references

release_xllx4hi755h7nowpisndlokdd4

1 reference

https://api.fatcat.wiki/v0/release/xllx4hi755h7nowpisndlokdd4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41789989&oldid=1927920800"